CPA
INVA icon

Capital Performance Advisors’s Innoviva INVA Stock Holding History

Capital Performance Advisors’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31
Closed -$599 – 1368
2024
Q3 		$599 Buy
+31
New +$571 ﹤0.01% 2163

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Performance Advisors's INVA Position: Q4 2024 in Review

Capital Performance Advisors sold out of Innoviva (INVA) in Q4 2024, closing a stake of 31 shares — an estimated $599 sold.

Capital Performance Advisors first reported a position in INVA in Q3 2024 and held it in 1 quarter. The position peaked at $599 in Q3 2024. 235 funds tracked by Wall St. Rank hold INVA as of Q4 2024.

  • Capital Performance Advisors reported no remaining Innoviva position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 31 Innoviva shares in Q4 2024, an estimated $599.
  • Capital Performance Advisors first reported a position in Innoviva in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Innoviva position peaked at $599 in Q3 2024.
  • 235 funds tracked by Wall St. Rank held Innoviva as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.